USRM (US Stem Cell) Institutional Ownership: 0.17% (As of Jul. 06, 2026)


USRM US Stem Cell Inc USRM
12 GF Score
Price $0.00
View Full Analysis

What is US Stem Cell Institutional Ownership?

US Stem Cell USRM -99.00% 12 Institutional Ownership is 0.17% as of Jul. 06, 2026. GuruFocus rates USRM with a GF Score™ of 12/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, US Stem Cell's institutional ownership is 0.17%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, US Stem Cell's Insider Ownership is 12.62%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, US Stem Cell's Float Percentage Of Total Shares Outstanding is 93.73%.

US Stem Cell Institutional Ownership Historical Data

* Premium members only.

The historical data trend for US Stem Cell's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

US Stem Cell Institutional Ownership Chart

US Stem Cell Historical Data

The historical data trend for US Stem Cell can be seen below:

2009-07-31 2009-08-31 2009-09-30 2009-10-31 2009-11-30 2009-12-31 2010-01-31 2010-02-28 2010-03-31 2010-04-30
Institutional Ownership 0.24 0.24 0.22 0.22 0.22 0.21 0.21 0.21 0.17 0.17
USRM
12GF Score
US Stem Cell Inc USRM
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

US Stem Cell Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.17% mean?
US Stem Cell (USRM) has a Institutional Ownership of 0.17% as of Jul. 06, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on US Stem Cell and its competitors.
Is US Stem Cell's Institutional Ownership too high?
US Stem Cell's current Institutional Ownership is 0.17%. Overall, US Stem Cell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does US Stem Cell's Institutional Ownership compare to NOVNQ and RGRX?
US Stem Cell's Institutional Ownership of 0.17% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on US Stem Cell and its competitors. US Stem Cell's current Institutional Ownership is 0.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Stem Cell stock overvalued right now?
US Stem Cell (USRM) has a current Institutional Ownership of 0.17%. The current Institutional Ownership is 0.17%. US Stem Cell's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For US Stem Cell (USRM), the current Institutional Ownership is 0.17% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

US Stem Cell Business Description

Address 1560 Sawgrass Corporate Parkway, 4th Floor, Sunrise, FL, USA, 33323
US Stem Cell Inc is a biotechnology company engaged in the discovery and development of autologous cell therapies for the treatment of chronic and acute heart damage. Its product includes MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's discoveries include multiple cell therapies in various stages of development that repair damaged tissues throughout the body due to injury or disease so that patients may return to a normal lifestyle.
12GF Score

Get the complete analysis for USRM

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price